This is the authors' abstract. We don't add key points for this paper.
Antimicrobial resistance (AMR) disproportionately affects low- and middle-income countries, yet perspectives and innovations from these regions remain underrepresented. During World Antimicrobial Awareness Week 2025, the AMR Knowledge Hub convened a four-day webinar series on AMR challenges and One Health solutions across three regions, with a country spotlight on Nigeria. Discussions highlight critical gaps in political commitment, sustainable financing, and locally relevant evidence, particularly on antibiotic stewardship. Regional and country experiences demonstrate the importance of context-specific research, locally driven innovation, and stronger governance. Integrating these voices into global AMR governance is essential for a more equitable, effective, and enduring response. Authors present their work on practitioner perspectives on antimicrobial resistance (AMR) from Africa, Asia, and the Middle East and North Africa, with a country spotlight on Nigeria, highlighting shared implementation gaps and locally driven innovations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ohemu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: